ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 29, 2015
Altria Outperforms; Smoking Marlboros Back on the Rise?
The tobacco and brewing giant may have run its course, but the dividend is solid.
Jul 29, 2015
Railroads Reveal Economic Concerns in the US
If it is produced, it must be shipped. The rails offer insight into the broader US economy, and it’s not as rosy as we would like.
Jul 29, 2015
3 Reasons Why Buffalo Wild Wings Is a Long-Term Winner
We’ll be looking to pick up this chicken-wing chain at the right price…again.
Jul 28, 2015
Quick Take: Gilead Blows By 2Q Estimates; Investors Getting Drug Pipeline for Free
We continue to like the company that found a way to cure hepatitis C.
Jul 28, 2015
The Chinese Market Is Rigged
Let’s face it. Nobody knows where the market clearing price is for most of the companies listed on the Chinese exchanges. The government won’t allow price discovery, which means “real” prices are far lower than today’s levels.
Jul 27, 2015
Not Throwing Away This Garbage Hauler
It may not be a glamourous business but it is a good one.
Jul 26, 2015
Dividend Increases for the Week Ending July 24
Let's take a look at companies raising their dividends this week.
Jul 26, 2015
Selecting Winners
Visa continues to be a key position in the Best Ideas Newsletter portfolio as it outpaces even the strength of its peers.
Jul 24, 2015
Organic Growth Sweetens Nonalcoholic Beverage Industry
Major players in the nonalcoholic beverage industry reported solid currency neutral results in the second quarter. Let’s take a look.
Jul 23, 2015
Guide to Second Quarter Earnings; Big Pharma Experiencing Earnings Momentum
Abbott, Bristol-Myers, Celgene, Eli Lilly, Novartis, Roche, Valeant…


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.